Immune Design Corp buy melinda
Start price
15.03.17
/
50%
€5.77
Target price
17.03.17
€6.31
Performance (%)
10.16%
End price
17.03.17
€6.36
Summary
This prediction ended on 17.03.17 with a price of €6.36. The prediction had a final performance of 10.16%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immune Design Corp | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by melinda for this prediction
In the thread Immune Design Corp diskutieren
Tumoren
CMB305
Krebs - soliden Tumoren
Stopped prediction by melinda for Immune Design Corp
Immune Design Corp
Start price
Target price
Perf. (%)
€4.56
01.11.17
01.11.17
€9.92
19.12.17
19.12.17
-23.27%
19.12.17
19.12.17
